[Department Circular No. 2021- 0079] Health Technology Assessment Council’s (HTAC) Recommendations on health technologies requiring Full Certificate of Registration (CPR) from the Food and Drug Administration
[Department Memorandum No. 2021- 0075] Compliance to dissemination of the recommendations of the Health Technology Assessment council (HTAC)
[Department Memorandum No. 2021- 0097] Health Technology Assessment Council’s (HTAC) Recommendations on COVID-19 heath technologies
[Memo to DOH Internal Offices] Acknowledgement of Comments_Concurrence on COVID-19 Vaccines Evaluation Framework
[Department Memorandum No. 2021- 0079] Endorsement of Topic Submissions from National Health Programs for HTA
COVID-19 Vaccine (ChAdOx1-S [recombinant]) (COVID-19 Vaccine AstraZeneca) for the prevention of COVID-19
HIGH-FLOW NASAL CANNULA OXYGEN THERAPY FOR THE TREATMENT OF ACUTE HYPOXEMIC RESPIRATORY FAILURE FOR COVID-19
